Providence Cancer Institute of Oregon

  • Dark genome, bright outcome: A first-of-its-kind trial gives Del Abbott a second chance

    Dark genome, bright outcome: A first-of-its-kind trial gives Del Abbott a second chance

    Del survived Arctic winters, a demanding career and cancer – twice. Here’s how a pioneering Providence Cancer Institute trial helped him beat it a second time.

    Read Article
  • A new liver cancer trial explores a “two-in-one" treatment approach

    A new liver cancer trial explores a “two-in-one" treatment approach

    Providence Cancer Institute is enrolling patients with hepatocellular carcinoma in a trial of pumitamig, an investigational bispecific antibody.

    Read Article
  • Providence Cancer Institute secures three significant grants

    Providence Cancer Institute secures three significant grants

    Prestigious grants will help researchers pursue important cancer studies.

    Read Article
  • Q&A: Meet one of the investigational drug pharmacists at Providence

    Q&A: Meet one of the investigational drug pharmacists at Providence

    An inside look at how a pharmacist at Providence Cancer Institute keeps clinical trials running safely, one dose at a time.

    Read Article
  • New T-cell therapy for KRAS G12D cancers

    New T-cell therapy for KRAS G12D cancers

    An expanded access program uses engineered T cells to target the KRAS G12D mutation in pancreatic, colorectal or other advanced cancers.

    Read Article
  • When standard treatment isn’t enough: A new study offers hope for people with triple-negative breast cancer

    When standard treatment isn’t enough: A new study offers hope for people with triple-negative breast cancer

    A new clinical trial is testing a promising drug combination that could improve survival for people whose cancer didn’t fully respond to standard treatment.

    Read Article
  • Hope comes in a clinical trial: Brad’s remarkable story

    Hope comes in a clinical trial: Brad’s remarkable story

    When Brad’s medullary thyroid cancer returned after a surgical procedure, he enrolled in a clinical trial. Now, his cancer is nearly undetectable.

    Read Article
  • Providence researchers head to Chicago for leading cancer conference

    Providence researchers head to Chicago for leading cancer conference

    Researchers at Earle A. Chiles Research Institute, a division of Providence Cancer Institute of Oregon, are helping shape the future of cancer care at the 2026 ASCO Annual Meeting in Chicago.

    Read Article
  • Adoptive cell therapy: Phase III study open for people with advanced melanoma

    Adoptive cell therapy: Phase III study open for people with advanced melanoma

    Inside the IMA203 phase III trial enrolling patients at Providence Cancer Institute.

    Read Article
  • It started with one bandage, and a patient’s smile

    It started with one bandage, and a patient’s smile

    How novelty bandages have become a beloved tradition at Providence Cancer Institute Newberg Clinic.

    Read Article
  • New guidelines for treating head and neck cancer could be a game changer

    New guidelines for treating head and neck cancer could be a game changer

    New ASCO guidelines are designed to make the full body of evidence accessible to clinicians across specialties, including those who may not work routinely with a head and neck surgeon.

    Read Article
  • Pioneering immunotherapy clinical trial enrolling patients with advanced cancers

    Pioneering immunotherapy clinical trial enrolling patients with advanced cancers

    A new medication called M3T01, developed at Providence Cancer Institute, takes a different approach to immunotherapy.

    Read Article
  • VOICES of Black Women: A community study in cancer prevention and care

    VOICES of Black Women: A community study in cancer prevention and care

    A new study focused on stories will change health outcomes for Black women.

    Read Article
  • Leading the way: Providence researchers at AACR Annual Meeting

    Leading the way: Providence researchers at AACR Annual Meeting

    The annual AACR meeting draws the most innovative cancer researchers seeking breakthroughs in treatments.

    Read Article
  • A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center

    A quiet lifeline: Meet the volunteer at Jill Lematta Learning Center

    Cancer resources and compassion are plentiful in a quiet space at Providence Cancer Institute Franz Clinic.

    Read Article
  • Gene therapy shows promising results against multiple myeloma

    Gene therapy shows promising results against multiple myeloma

    This study is now enrolling patients at Providence Cancer Institute – the only site outside of Australia.

    Read Article
  • Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention

    Q&A: Colon cancer in younger adults, when to screen, symptoms and prevention

    Dr. Kelly Perlewitz answers timely questions about the rise of colon cancer cases in younger adults.

    Read Article
  • Celebrating oncology social workers: Compassion, expertise and impact

    Celebrating oncology social workers: Compassion, expertise and impact

    We celebrate the work of oncology social workers, whose work is essential, transformative and deeply human.

    Read Article
  • 6 things everyone should know about oncology palliative care

    6 things everyone should know about oncology palliative care

    Palliative care can help manage pain, fatigue, anxiety and so much more – at any stage of cancer treatment.

    Read Article
  • Clinical trial seeks better first-line therapy for follicular lymphoma

    Clinical trial seeks better first-line therapy for follicular lymphoma

    The study may redefine care for many people at the earliest stage of their treatment.

    Read Article
  • loading
    Loading More...